Skip to main content
. 2017 Jul 20;38(4):192–198. doi: 10.4082/kjfm.2017.38.4.192

Table 4. Primary and secondary outcomes of control and fenofibrate groups.

graphic file with name kjfm-38-192-i004.jpg

Values are presented as mean±standard deviation or number (%). Continuous variables were analyzed using the t-test and categorical variables were analyzed using the chisquare test with the exception of eGFR decrease ≥20 mL/min·1.73 m2 and eGFR decrease ≥20%.

Cr, creatinine; eGFR, estimated glomerular filtration rate.

*Calculated using Chronic Kidney Disease Epidemiology Collaboration guidelines. Which were analyzed by Fisher's exact test.